TickerFacts.

NewGenIvf Group Ltd (NIVF): Operating Income

Annual figures by period end, from SEC filings.

-$10.73M
Year ended 2025-12-31
$398.7K2021-12-31: $198.8K2022-12-31: $398.7K2023-12-31: $42.2K2024-12-31: -$1.16M2025-12-31: -$10.73M-$10.73M
2021-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$10.73Mn/m2026-03-31, From 2025-01-01
2024-12-31-$1.16Mn/m2026-03-31, From 2024-01-01
2023-12-31$42.2K-89.4%2026-03-31, From 2023-01-01
2022-12-31$398.7K+100.6%2025-05-15, From 2022-01-01
2021-12-31$198.8Kn/a2024-08-20, From 2021-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
NewGenIvf Group Ltd (NIVF)2025-12-31-$10.73Mn/m
Cryo Cell International Inc (CCEL)2025-11-30$482.4K-86.1%
Mangoceuticals, Inc. (MGRX)2025-12-31-$18.03Mn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$1.00M+17.4%
Marpai, Inc. (MRAI)2025-12-31-$13.55Mn/m
Charming Medical Ltd (MCTA)2026-03-31-$29.2Kn/m
Viemed Healthcare, Inc. (VMD)2025-12-31$22.95M+28.2%
BioRestorative Therapies, Inc. (BRTX)2025-12-31-$15.65Mn/m
Progyny, Inc. (PGNY)2025-12-31$85.28M+26.4%

Compare NIVF, CCEL, MGRX, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗